Indications | Sublingual misoprostol (n = 98) | Vaginal misoprostol (n = 100) | RR | 95% CI | p-value* | ||
---|---|---|---|---|---|---|---|
n | % | n | % | ||||
Hypertensive syndromes | 53 | 54.1 | 32 | 32.0 | 1.56 | 1.18–2.07 | 0.002 |
Prolonged pregnancy | 20 | 20.4 | 32 | 32.0 | 0.72 | 0.49–1.05 | 0.06 |
Premature rupture of membranes | 9 | 9.2 | 6 | 6.0 | 1.23 | 0.79–1.91 | 0.39 |
Diabetes | 16 | 16.3 | 25 | 25.0 | 0.75 | 0.49–1.13 | 0.13 |
Others | 12 | 12.2 | 11 | 11.0 | 1.06 | 0.69–1.61 | 0.78 |